Abstract
Multiparametric magnetic resonance imaging (MRI) is an important diagnostic tool to stage rectal cancer and to assess the impact of treatment and has been recommended by both the European Society of Gastrointestinal and Abdominal Radiology and the Society of Abdominal Radiology (SAR) Rectal and Anal Cancer Disease-Focused Panel (1,2). In particular, diffusion-weighted imaging (DWI) provides useful information, especially following neoadjuvant chemoradiotherapy and has become a routine part of the rectal cancer MRI examination (3-7).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
